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Results: In this study, 221(93%) GNB were conﬁrmed ESBL
producers (range between centers, 74 to 99%) of which 94%
were nosocomial in origin. ESBL in intensive care unit (ICU)
and non-ICU patients was 86% and 98% respectively. Among
ESBLs in ICU, 13.5% were community acquired. Resistance
to LEV was 73.3% > P/T 27.3% and >AMK 12.3%. No resis-
tance to IMP and MER seen. Overall 61% were MDR. Four KS
(1.7%) isolates were resistant to ERT. PCR showed blaCTX-
M in 73%, blaTEM in 56% and blaSHV in 38%. Multiple genes
were present in 60%.
Conclusion: Prevalence of ESBL among GNB causing infec-
tions continues to be high in Indian medical centers. ERT
shows good activity equivalent to the tested Group 2 car-
bapenems and may be considered for treatment of such
infections.
doi:10.1016/j.ijid.2008.05.279
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Objectives: MacConkey agar with ceftazidime (CMAC)
was used for early detection of extended spectrum beta-
lactamase(ESBL) for clinical sample received from ICU.
Methods: A total of 374 clinical samples were received
from ICU in the Dept. of Microbiology. Along with Mac-
Conkey agar and Blood agar, the samples were processed on
MacConkey agar with ceftazidime (1mg/L) for provisional
detection of ESBL isolates. Lactose -fermenting colonies on
MacConkey agar with ceftazidime(CMAC) were provisionally
detected as ESBL producing isolates. These isolates were
identiﬁed by standard methods. Presence of ESBL was deter-
mined by CLSI method (cefotaxime and ceftazidime disks
with and without clavulinic acid).
Results: 128 isolates showed growth on CMAC of which
50 were lactose fermenters. 31 isolates were identiﬁed as
E.coli and 19 as K.pneumoniae. All the 50 isolates were
identiﬁed as conﬁrmed ESBL producers.
Conclusion: Compared to phenotypic identiﬁcation of
ESBL producers, CMAC helps in early detection ESBLs which
can be very useful from treatment point of view. Since in
our hospital we have about 60% of ICU patients growing ESBL
producers, this early detection helps the intensivist to start
anti-ESBL therapy.
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Background: Indiscriminate use of beta-lactam antibi-
otics has resulted in emergence of AmpC Beta-lactamases.
Considering the lack of comprehensive studies from India
the present study was undertaken to detect and character-
ize AmpC Beta-lactamases in clinical isolates of Escherichia
coli and Klebsiellaspp.
Methods: One hundred non-repeat clinical isolates each
of Escherichia coli and Klebsiella spp recovered from pus,
urine, blood and sputum, were collected from various hos-
pitals of Delhi. These were screened for susceptibility to
cefoxitin (30g) by disc diffusion method. The screen pos-
itive isolates were subjected to Modiﬁed 3 Dimensional
test (M3D), AmpC disk tests 1 and 2 and Inhibitor (Boronic
acid) based detection method. AmpC positive isolates were
subjected to Polymerase chain reaction (PCR) using family
speciﬁc primers and also tested for production of ESBLs and
inducible AmpC Beta-lactamases.
Results: 34/100 (34%) of Escherichia coli and 21/100
(21%) of Klebsiella spp. were resistant to cefoxitin. Of the
screen positive isolates 12 (35%) of Escherichia coli, and 5
(24%) of Klebsiella spp. were positive for AmpC by various
phenotypic tests. Out of the AmpC positive isolates as many
as 8/12 of Escherichia coli and 3/5 of Klebsiella isolates
were positive for ESBLs. In 3/12 (25%) of Escherichia coli
and 3/5 (60%) of Klebsiella isolates AmpC were inducible.
PCR identiﬁed the AmpC of Escherichia coli as MIR/ACT-
I and CIT types. Amongst Klebsiella isolates, the AmpC
were found to be of MIR/ACTI, CIT, FOX and DHA fami-
lies.
Conclusion: The incidence of AmpC production was
higher (12%) in Escherichia coli than in Klebsiella (5%) iso-
lates. However, co-production of ESBLs was much higher in
Klebsiella (60%) than in Escherichia coli (25%) isolates. The
AmpC Beta-lactamases in Indian isolates were of common
families reported from different parts of the world.
doi:10.1016/j.ijid.2008.05.281
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Objectives: Urinary tract infections (UTI) are one of the
most common infectious diseases diagnosed in outpatients
and also constitutes the most common nosocomial infection
in many hospitals. Escsherichia coli remains the principal
causative pathogen of UTIs both in outpatients and inpa-
tients. In this study it was aimed to compare the resistance
patterns of E. coli strains reported to be isolated from urine
